Literature DB >> 18446409

Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm.

Thomas E Mayer1, Martin Dichgans, Andreas Straube, Tobias Birnbaum, Stephanie Müller-Schunk, Gerhard F Hamann, Gernot Schulte-Altedorneburg.   

Abstract

Two patients with refractory symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) were treated by continuous intra-arterial nimodipine infusion via a catheter placed in the internal carotid artery or vertebral artery for 3 and 12 days, respectively. Recovery of the neurological deficits, normalization of MR perfusion, a decrease in the elevated mean flow velocity measured by transcranial duplex sonography, and angiographic recanalization were observed. Continuous intra-arterial nimodipine might be a treatment option in severe refractory vasospasm following SAH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446409     DOI: 10.1007/s00270-008-9346-0

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  11 in total

1.  Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.

Authors:  F Seker; J Hesser; M A Brockmann; E Neumaier-Probst; C Groden; R Schubert; C Brockmann
Journal:  Clin Neuroradiol       Date:  2015-09-08       Impact factor: 3.649

2.  Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.

Authors:  W-S Cho; H-S Kang; J E Kim; O-K Kwon; C W Oh; Y J Son; B J Know; C Jung; M H Hang
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

3.  Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage.

Authors:  Martin Kieninger; Julia Flessa; Nicole Lindenberg; Sylvia Bele; Andreas Redel; André Schneiker; Gerhard Schuierer; Christina Wendl; Bernhard Graf; Vera Silbereisen
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

Review 4.  In cold blood: intraarteral cold infusions for selective brain cooling in stroke.

Authors:  Elga Esposito; Matthias Ebner; Ulf Ziemann; Sven Poli
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

5.  Dose-response relationship of locally applied nimodipine in an ex vivo model of cerebral vasospasm.

Authors:  Fatih Seker; Jürgen Hesser; Eva Neumaier-Probst; Christoph Groden; Marc A Brockmann; Rudolf Schubert; Carolin Brockmann
Journal:  Neuroradiology       Date:  2012-08-05       Impact factor: 2.804

6.  Magnetic Resonance Imaging in Aneurysmal Subarachnoid Hemorrhage: Current Evidence and Future Directions.

Authors:  Sarah E Nelson; Haris I Sair; Robert D Stevens
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

7.  Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm.

Authors:  S Wolf; H Martin; J F Landscheidt; S O Rodiek; L Schürer; C B Lumenta
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

8.  Continuous Local Intra-Arterial Nimodipine for the Treatment of Cerebral Vasospasm.

Authors:  Nicola Logallo; Marianne Lundervik Bøthun; Anne Berit Guttormsen; Gunhild Holmaas; Jostein Kråkenes; Lars Thomassen; Frode Svendsen; Christian A Helland
Journal:  J Neurol Surg Rep       Date:  2015-03-04

9.  Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.

Authors:  Stephanie Ott; Sheila Jedlicka; Stefan Wolf; Mozes Peter; Christine Pudenz; Patrick Merker; Ludwig Schürer; Christianto Benjamin Lumenta
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

10.  Successful use of continuous vasodilator infusion to treat critical vasospasm threatening a distal bypass.

Authors:  Gregory A Magee; Anastasia Plotkin; Jeniann A Yi; Kathryn E Bowser; David P Kuwayama
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.